Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Nyman

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Head & Neck|January 9, 2024
A randomized study comparing the nutritional effects of radiotherapy with cetuximab versus cisplatin in patients with advanced head and neck cancerMalin Berg, Camilla Hansson, Ewa Silander, et al.
Cancers|May 14, 2022
<i>KRAS</i> Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung CancerElla A Eklund, Clotilde Wiel, Henrik Fagman, et al.
Head & Neck|October 8, 2025
Effect of a Home-Based Exercise Program on Muscle Mass, Fatigue, and Health-Related Quality of Life Among Patients with Oral Cancer: A Randomized TrialCamilla Wallmander, Ingvar Bosaeus, Ewa Silander, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trialAndreas Hallqvist, Stefan Bergström, Hedvig Björkestrand, et al.
JTO Clinical and Research Reports|September 10, 2025
Monotherapy With Immune Checkpoint Blockade Improves Survival Outcomes in KRAS-Mutant but Not KRAS Wild-Type Metastatic Lung Adenocarcinoma: Validation From an Extended Swedish CohortElla A Eklund, Sama I Sayin, Jonas Smith Jonsson, et al.
Radiation Research|March 21, 2020
Epidermal Keratinocyte Depletion during Five Weeks of Radiotherapy is Associated with DNA Double-Strand Break Foci, Cell Growth Arrest and Apoptosis: Evidence of Increasing Radioresponsiveness and Lack of Repopulation; the Number of Melanocytes Remains UnchangedIngela Turesson, Martin Simonsson, Ingegerd Hermansson, et al.
Acta Oncologica (Stockholm, Sweden)|March 28, 2015
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experienceKarin Lindberg, Jan Nyman, Vendela Riesenfeld Källskog, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2016
SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLCJan Nyman, Andreas Hallqvist, Jo-Åsmund Lund, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2014
Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiationMarie Kalm, Edvard Abel, Pontus Wasling, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial treeKristin Karlsson, Jan Nyman, Pia Baumann, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Head & Neck|January 9, 2024
A randomized study comparing the nutritional effects of radiotherapy with cetuximab versus cisplatin in patients with advanced head and neck cancerMalin Berg, Camilla Hansson, Ewa Silander, et al.
Cancers|May 14, 2022
<i>KRAS</i> Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung CancerElla A Eklund, Clotilde Wiel, Henrik Fagman, et al.
Head & Neck|October 8, 2025
Effect of a Home-Based Exercise Program on Muscle Mass, Fatigue, and Health-Related Quality of Life Among Patients with Oral Cancer: A Randomized TrialCamilla Wallmander, Ingvar Bosaeus, Ewa Silander, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trialAndreas Hallqvist, Stefan Bergström, Hedvig Björkestrand, et al.
JTO Clinical and Research Reports|September 10, 2025
Monotherapy With Immune Checkpoint Blockade Improves Survival Outcomes in KRAS-Mutant but Not KRAS Wild-Type Metastatic Lung Adenocarcinoma: Validation From an Extended Swedish CohortElla A Eklund, Sama I Sayin, Jonas Smith Jonsson, et al.
Radiation Research|March 21, 2020
Epidermal Keratinocyte Depletion during Five Weeks of Radiotherapy is Associated with DNA Double-Strand Break Foci, Cell Growth Arrest and Apoptosis: Evidence of Increasing Radioresponsiveness and Lack of Repopulation; the Number of Melanocytes Remains UnchangedIngela Turesson, Martin Simonsson, Ingegerd Hermansson, et al.
Acta Oncologica (Stockholm, Sweden)|March 28, 2015
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experienceKarin Lindberg, Jan Nyman, Vendela Riesenfeld Källskog, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2016
SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLCJan Nyman, Andreas Hallqvist, Jo-Åsmund Lund, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2014
Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiationMarie Kalm, Edvard Abel, Pontus Wasling, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial treeKristin Karlsson, Jan Nyman, Pia Baumann, et al.
Pageof 7